Home
Resources
Follow portfolio news
...

Cardiac technology: corpuls acquires Hestomed Nord

Published on
9/1/2025
Amended on
23/3/2026
0
minute(s)
Odyssey 2021
corpuls
Specializing in medical technologies dedicated to cardiotherapy, corpuls has been designing innovative, robust equipment for use in emergency care and preclinical medicine for over 35 years. Based in Bavaria, the company continues to expand with the acquisition of long-standing partner Hestomed Nord.
By
Charles Pinsolle
Charles Pinsolle
Cardiac technology: corpuls acquires Hestomed Nord
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
Questo articolo è stato tradotto automaticamente. Ci scusiamo per eventuali inesattezze o errori di traduzione.

A historic collaboration transformed into a growth opportunity

Present in the Vintage Altaroc Odyssey 2021, corpuls plans to strengthen its presence in the German market with this acquisition. Hestomed Nord, exclusive distributor of corpuls products for several decades, will officially become a subsidiary of the Bavarian company at the beginning of this year.

"This merger will enable us to offer our customers an optimized service and consolidate our leading position in the sector. The integration of Hestomed Nord's experienced team is a logical and pleasing step for corpuls" said Christian Klimmer, CEO of corpuls.

Smooth, ambitious integration

The 32 Hestomed Nord employees will join the corpuls team, ensuring continuity of service for customers. The Stockelsdorf site in Schleswig-Holstein, with its advanced logistics capabilities including workshop, warehouse and training facilities, will remain fully operational.

Sven Larsen, current Co-Director of Hestomed Nord, will take sole charge of the subsidiary, saying: "This partnership with one of the world's leading manufacturers of medical technology opens up immense opportunities. corpuls has ambitious plans, and our team is proud to be part of this adventure."

With this acquisition, corpuls consolidates its commitment to innovation and excellence. Since its foundation in 1982, the German company has established itself as a key player in the field of defibrillators, medical monitors and chest compression devices. Currently present in over 60 countries, corpuls continues to push back technological boundaries to meet the needs of healthcare professionals and patients worldwide.

Other episodes on this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
No articles in this category yet.
No items found.
Europe
Healthcare
Welcome to Altaroc
To provide you with a tailored experience, we invite you to complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
Your investor profile
Financial intermediary or Professional investor
Financial advisors, wealth management advisors, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced Investor or Altaroc Investor
Private investors who have already invested in Altaroc who have a minimum investment capacity of €100,000.
Private investors who have already invested in Altaroc who have a minimum investment capacity of €250,000.
Inexperienced investor
Individual investors with an investment capacity of less than €100,000.
Individual investors with an investment capacity of less than €250,000.
Institutional investor
Pension funds, retirement funds, asset management firms, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.